Diversified Consumer Services
Company Overview of University of California, Los Angeles
University of California, Los Angeles is an educational institution that offers undergraduate and graduate programs in the fields of arts and architecture, dentistry, education and information studies, law, management, medicine, nursing, and public health. The institution was formerly known as UC's Southern Branch and changed its name to University of California, Los Angeles in 1927. The institution was founded in 1919 and is based in Los Angeles, California. University of California, Los Angeles is a part of University of California.
405 Hilgard Avenue
Los Angeles, CA 90095-1361
Founded in 1919
Key Executives for University of California, Los Angeles
Professor in the Department of Molecular and Medical Pharmacology
Executive Vice Chancellor and Provost
Executive Director of the Wireless Health Institute
Compensation as of Fiscal Year 2017.
University of California, Los Angeles Key Developments
GWG Holdings Announces its Exclusive License of Mortality Predictive Technology from UCLA for Life Insurance Industry
May 4 17
GWG Holdings Inc. announced it has completed its exclusive license with the University of California, Los Angeles (UCLA) for the DNA Methylation Based Predictor of Mortality technology for application to the life insurance and related industries. The technology, invented by Dr. Steve Horvath, a professor of human genetics at the David Geffen School of Medicine at UCLA, provides life expectancy estimates based upon epigenetic biomarkers. Epigenetics differs from genetics in that epigenetics do not include changes to the genetic sequence. GWG Holdings announced previously that it had optioned the technology in November to begin developing a commercial application of the technology's ability to deliver more accurate life expectancy projections for the life insurance industry. Since that time, GWG Life has been actively pursuing the commercialization of the epigenetic-based technology in what is called: M-Panel technology. The M-Panel technology measures the methylation of CpG sites identified by Dr. Horvath as biomarkers indicative of biological aging.
EpicGenetics Enters into Agreement with University of California Los Angeles and University of Illinois College of Medicine at Chicago
Apr 20 17
EpicGenetics,has entered into an agreement with University of California Los Angeles (UCLA), and the University of Illinois College of Medicine at Chicago, a research institute, to expand clinical study of FM/a test to diagnose fibromyalgia, identify genetic markers unique to the disorder and explore direct treatment approaches. FM/a Test is an FDA-compliant blood test that diagnoses fibromyalgia by identifying the presence of specific white blood cell abnormalities. Under the agreement, both university research centers will be sequencing the exomes of patients to improve the diagnosis of fibromyalgia through the application of the FM/a test and to allow EpicGenetics to detect fibromyalgia disease-specific gene markers. In addition, Bruce Gillis, managing director of EpicGenetics, has made a research gift to the Immunobiology Laboratory at the Massachusetts General Hospital directed by Denise Faustman, managing director, to continue its robust clinical research regarding a direct treatment for fibromyalgia. This agreement enables EpicGenetics, UCLA and University of Illinois College of Medicine at Chicago to expand clinical study of FM/a test to diagnose fibromyalgia.
UCLA Trade Workers Authorize Strike
Nov 5 16
Members of a union representing nearly 600 skilled-trades workers at University of California, Los Angeles have voted to strike but university officials say no service disruptions are anticipated. About 200 skilled-trades workers at UC San Diego plan to strike the next day. The union announced that 96% of employees voted to strike after working without a contract for the last four years. Rabinowitz accused UCLA of dragging out negotiations to avoid having to increase wages during that time. The union wants a retroactive payment of 20.39% of wages and annual pay increases of 17.39%, 5% and 4%.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|